Concepedia

Publication | Closed Access

G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab

DOI

54

Citations

36

References

2015

Year

Ondřej Fiala, Tomáš Büchler, Beatrice Mohelníková-Duchoňová, Bohuslav Melichar, Vít Martin Matějka, L Holubec, J Kulhánková, Zbyněk Bortlíček, Marie Bartoušková, Václav Liška,
Tumor Biology

References

YearCitations

Page 1